Log In
Print this Print this

Cannabidivarin (CBDV) (GWP42006)

  Manage Alerts
Collapse Summary General Information
Company GW Pharmaceuticals plc
DescriptionNon-psychoactive cannabinoid cannabidivarin (CBDV) extracted from specific chemotypes of the Cannabis plant
Molecular Target Cannabinoid receptors
Mechanism of ActionCannabinoid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationEpilepsy
Indication DetailsTreat epilepsy
Regulatory Designation
PartnerOtsuka Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today